المؤلفون: Del Re M., Crucitta S., Gianfilippo G., Passaro A., Petrini I., Restante G., Michelucci A., Fogli S., de Marinis F., Porta C., Chella A., Danesi R.

المساهمون: Del Re, M., Crucitta, S., Gianfilippo, G., Passaro, A., Petrini, I., Restante, G., Michelucci, A., Fogli, S., de Marinis, F., Porta, C., Chella, A., Danesi, R.

مصطلحات موضوعية: Circulating cell-free DNA, Epidermal growth factor receptor, Liquid biopsy, Mechanisms of resistance, Non-small cell lung cancer, Tyrosine kinase inhibitor, Animal, Biomarkers, Tumor, Carcinoma, Non-Small-Cell Lung, Circulating Tumor DNA, Clinical Decision-Making, Disease Management, Drug Resistance, Neoplasm, ErbB Receptor, Human, Lung Neoplasm, Molecular Targeted Therapy, Mutation, Protein Kinase Inhibitors

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31416192; info:eu-repo/semantics/altIdentifier/wos/WOS:000484411100108; volume:20; issue:16 Article Number: 3951; firstpage:1; lastpage:16; numberofpages:16; journal:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES; http://hdl.handle.net/11586/327466Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85071041777

الإتاحة: https://doi.org/10.3390/ijms20163951Test
http://hdl.handle.net/11586/327466Test

المؤلفون: Danesi, R., Petrini, I., Mazzoni, F., Valleggi, S., Gianfilippo, G., Pozzessere, D., Crucitta, S., Restante, G., Chella, A., Garassino, M.C., Miccoli, M., De Re, M.l.

المصدر: Annals of Oncology ; volume 30, page v643 ; ISSN 0923-7534

مصطلحات موضوعية: Oncology, Hematology

الإتاحة: https://doi.org/10.1093/annonc/mdz260.083Test
https://api.elsevier.com/content/article/PII:S092375341959768X?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S092375341959768X?httpAccept=text/plainTest
http://academic.oup.com/annonc/article-pdf/30/Supplement_5/mdz260.083/30084868/mdz260.083.pdfTest

المؤلفون: Fogli S., Gianfilippo G., Cucchiara F., Del Re M., Valerio L., Elisei R., Danesi R.

المساهمون: Fogli, S., Gianfilippo, G., Cucchiara, F., Del Re, M., Valerio, L., Elisei, R., Danesi, R.

مصطلحات موضوعية: Adverse drug reaction, Drug-drug interaction, Lenvatinib, Pharmacodynamic, Pharmacokinetic, Drug Interaction, Human, Phenylurea Compound, Protein Kinase Inhibitor, Vascular Endothelial Growth Factor A, Pharmaceutical Preparation, Pharmacology, Clinical, Quinoline, Thyroid Neoplasms

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34051303; info:eu-repo/semantics/altIdentifier/wos/WOS:000674448900003; volume:163; firstpage:1; lastpage:7; numberofpages:7; journal:CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY; http://hdl.handle.net/11568/1116664Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85108144589

الإتاحة: https://doi.org/10.1016/j.critrevonc.2021.103366Test
http://hdl.handle.net/11568/1116664Test

المؤلفون: Del Re M., Petrini I., Mazzoni F., Valleggi S., Gianfilippo G., Pozzessere D., Chella A., Crucitta S., Rofi E., Restante G., Miccoli M., Garassino M. C., Danesi R.

المساهمون: Del Re, M., Petrini, I., Mazzoni, F., Valleggi, S., Gianfilippo, G., Pozzessere, D., Chella, A., Crucitta, S., Rofi, E., Restante, G., Miccoli, M., Garassino, M. C., Danesi, R.

مصطلحات موضوعية: Drug resistance, EGFR, Mutation, Non-squamous non-small cell lung cancer, Tyrosine kinase inhibitors

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31735523; info:eu-repo/semantics/altIdentifier/wos/WOS:000528327300020; volume:21; issue:3; firstpage:232; lastpage:237; numberofpages:6; journal:CLINICAL LUNG CANCER; https://hdl.handle.net/11568/1019101Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85075350624; https://www.clinical-lung-cancer.com/article/S1525-7304Test(19)30268-2/abstract

الإتاحة: https://doi.org/10.1016/j.cllc.2019.10.003Test
https://hdl.handle.net/11568/1019101Test
https://www.clinical-lung-cancer.com/article/S1525-7304Test(19)30268-2/abstract

المؤلفون: Rofi E., Del Re M., Arrigoni E., Rizzo M., Fontanelli L., Crucitta S., Gianfilippo G., Restante G., Fogli S., Porta C., Danesi R., Schmidinger M.

المساهمون: Rofi, E., Del Re, M., Arrigoni, E., Rizzo, M., Fontanelli, L., Crucitta, S., Gianfilippo, G., Restante, G., Fogli, S., Porta, C., Danesi, R., Schmidinger, M.

مصطلحات موضوعية: PD-L1 inhibitor, Pharmacodynamic, Pharmacokinetic, Urothelial cancer

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32340783; info:eu-repo/semantics/altIdentifier/wos/WOS:000574926800003; volume:154; firstpage:1; lastpage:10; numberofpages:10; journal:CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY; http://hdl.handle.net/11568/1053751Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85083708258

الإتاحة: https://doi.org/10.1016/j.critrevonc.2020.102891Test
http://hdl.handle.net/11568/1053751Test

المؤلفون: Fogli S., Porta C., Del Re M., Crucitta S., Gianfilippo G., Danesi R., Rini B. I., Schmidinger M.

المساهمون: Fogli, S., Porta, C., Del Re, M., Crucitta, S., Gianfilippo, G., Danesi, R., Rini, B. I., Schmidinger, M.

مصطلحات موضوعية: Angiogenesi, Pharmacology, RCC, Tivozanib, VEGFR-TKI, Angiogenesis Inhibitor, Anilide, Axitinib, Carcinoma, Renal Cell, Drug Interaction, Human, Kidney Neoplasm, Phenylurea Compound, Protein Kinase Inhibitor, Pyridine, Pyrimidine, Quinoline, Receptors, Vascular Endothelial Growth Factor, Sorafenib, Sulfonamide, Sunitinib

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32044644; info:eu-repo/semantics/altIdentifier/wos/WOS:000517347600007; volume:84; firstpage:101966; numberofpages:9; journal:CANCER TREATMENT REVIEWS; http://hdl.handle.net/11586/327932Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85078963404

الإتاحة: https://doi.org/10.1016/j.ctrv.2020.101966Test
http://hdl.handle.net/11586/327932Test

المؤلفون: Rofi E., Del Re M., Arrigoni E., Rizzo M., Fontanelli L., Crucitta S., Gianfilippo G., Restante G., Fogli S., Porta C., Danesi R., Schmidinger M.

المساهمون: Rofi, E., Del Re, M., Arrigoni, E., Rizzo, M., Fontanelli, L., Crucitta, S., Gianfilippo, G., Restante, G., Fogli, S., Porta, C., Danesi, R., Schmidinger, M.

مصطلحات موضوعية: PD-L1 inhibitor, Pharmacodynamic, Pharmacokinetic, Urothelial cancer, Antibodies, Monoclonal, B7-H1 Antigen, Carcinoma, Transitional Cell, Human, Immunotherapy, Programmed Cell Death 1 Receptor, Urinary Bladder Neoplasms

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31698313; info:eu-repo/semantics/altIdentifier/wos/WOS:000502892600014; volume:144; firstpage:102812; numberofpages:10; journal:CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY; http://hdl.handle.net/11586/327480Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85074340609

الإتاحة: https://doi.org/10.1016/j.critrevonc.2019.09.004Test
http://hdl.handle.net/11586/327480Test

المؤلفون: Rofi E., Del Re M., Arrigoni E., Rizzo M., Fontanelli L., Crucitta S., Gianfilippo G., Restante G., Fogli S., Porta C., Danesi R., Schmidinger M.

المساهمون: Rofi, E., Del Re, M., Arrigoni, E., Rizzo, M., Fontanelli, L., Crucitta, S., Gianfilippo, G., Restante, G., Fogli, S., Porta, C., Danesi, R., Schmidinger, M.

مصطلحات موضوعية: PD-L1 inhibitor, Pharmacodynamic, Pharmacokinetic, Urothelial cancer, Antibodies, Monoclonal, B7-H1 Antigen, Carcinoma, Transitional Cell, Human, Immunotherapy, Programmed Cell Death 1 Receptor, Urinary Bladder Neoplasms

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31698313; info:eu-repo/semantics/altIdentifier/wos/WOS:000502892600014; volume:144; firstpage:1; lastpage:10; numberofpages:10; journal:CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY; http://hdl.handle.net/11568/1071487Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85074340609

الإتاحة: https://doi.org/10.1016/j.critrevonc.2019.09.004Test
http://hdl.handle.net/11568/1071487Test

المؤلفون: Crucitta S., Restante G., Del Re M., Bertolini I., Bona E., Rofi E., Fontanelli L., Gianfilippo G., Fogli S., Stasi I., Ghilli M., Fontana A., Danesi R.

المساهمون: Crucitta, S., Restante, G., Del Re, M., Bertolini, I., Bona, E., Rofi, E., Fontanelli, L., Gianfilippo, G., Fogli, S., Stasi, I., Ghilli, M., Fontana, A., Danesi, R.

مصطلحات موضوعية: Adverse event, Bevacizumab, Breast cancer, eNOS, Pharmacogenetic, Polymorphism, Proteinuria

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31529205; info:eu-repo/semantics/altIdentifier/wos/WOS:000497443600009; volume:84; issue:6; firstpage:1219; lastpage:1227; numberofpages:9; journal:CANCER CHEMOTHERAPY AND PHARMACOLOGY; http://hdl.handle.net/11568/1019097Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85073934277; link.springer.de/link/service/journals/00280/index.htm

الإتاحة: https://doi.org/10.1007/s00280-019-03933-zTest
http://hdl.handle.net/11568/1019097Test

المؤلفون: Re M. D., Gianfilippo G., Crucitta S., Addeo A., Van Schaik R. H. N., Danesi R.

المساهمون: Re, M. D., Gianfilippo, G., Crucitta, S., Addeo, A., Van Schaik, R. H. N., Danesi, R.

مصطلحات موضوعية: Circulating biomarker, immunotherapy, predictive biomarker, solid tumors

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31691637; info:eu-repo/semantics/altIdentifier/wos/WOS:000507616100001; volume:20; issue:18; firstpage:1247; lastpage:1249; numberofpages:3; journal:PHARMACOGENOMICS; http://hdl.handle.net/11568/1019099Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85076402666; http://www.futuremedicine.com/loi/pgs?cookieSet=1Test

الإتاحة: https://doi.org/10.2217/pgs-2019-0117Test
http://hdl.handle.net/11568/1019099Test
http://www.futuremedicine.com/loi/pgs?cookieSet=1Test